Jay H. Shubrook, DO, FAAFP, FACOFP - Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health

About this episode

The episode discusses the potential of incretin-based therapies in managing type 2 diabetes and strategies for improving cardiometabolic health in primary care.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/MVY865. CME/AAPA credit will be available until May 15, 2027. Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Lilly. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guest: Jay H. Shubrook, DO, FAAFP, FACOFP

Topics covered

• incretin-based therapies
• type 2 diabetes
• primary care strategies
• cardiometabolic health
• healthcare education

Keywords

• incretin
• type 2 diabetes
• cardiometabolic health
• primary care
• CME
• healthcare professionals
• education

Sponsors

Lilly

Mentioned in this episode

Organizations: PVI, PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC)

More episodes of PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast

• Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes · June 5, 2026 · 32 min
• Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition · May 29, 2026 · 1h 11m
• Anna Chodos, MD, MPH - Getting Ahead of Cognitive Decline—Applying Patient-Centered Strategies to Assess and Reduce Dementia Risk in Primary Care: An AI-Guided Case Simulation Activity · May 29, 2026 · 46 min
• Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution · May 29, 2026 · 55 min
• Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice · May 29, 2026 · 38 min
• Professor Frank Jessen, MD - AD/PD 2026: Advancing Alzheimer’s Disease Detection, Diagnosis, and Treatment Through New Evidence · May 25, 2026 · 32 min